Medika d.d. (ZSE:MDKA)
Croatia · Delayed Price · Currency is EUR 4,540.00
+20.00 (0.44%)
At close: Mar 20, 2026
Medika d.d. Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 27.78 | 20.31 | 20.08 | 15.5 | 13.24 |
Depreciation & Amortization | 6.11 | 4.35 | 3.89 | 4.04 | 3.89 |
Other Amortization | - | 0.44 | 0.44 | - | - |
Loss (Gain) From Sale of Assets | 0.71 | -0.14 | -1.08 | -0.9 | -0.08 |
Asset Writedown & Restructuring Costs | - | - | - | 0.12 | - |
Loss (Gain) From Sale of Investments | 0.37 | - | - | - | - |
Loss (Gain) on Equity Investments | - | -0.51 | -0.43 | -0.43 | -0.38 |
Stock-Based Compensation | - | 0.48 | 0.47 | 0.45 | 0.67 |
Provision & Write-off of Bad Debts | - | 0.17 | 0.08 | 0.09 | -0.1 |
Other Operating Activities | -9.9 | -0.85 | -1.57 | -0.68 | -0.11 |
Change in Accounts Receivable | -58.87 | -46.3 | -31.31 | -37.15 | 41.72 |
Change in Inventory | -22.71 | -15.07 | -17.34 | -15.42 | 1.3 |
Change in Accounts Payable | - | 6.06 | 48.69 | 43.52 | -15.79 |
Change in Other Net Operating Assets | 77.84 | - | - | - | - |
Operating Cash Flow | 21.32 | -31.08 | 21.95 | 9.13 | 44.36 |
Operating Cash Flow Growth | - | - | 140.38% | -79.42% | 208.98% |
Capital Expenditures | -9.67 | -3.47 | -2.37 | -1.8 | -8.48 |
Sale of Property, Plant & Equipment | 0.17 | 0.18 | 2.99 | 0.96 | 0.36 |
Cash Acquisitions | -0.88 | - | -2.1 | -1.62 | -1.4 |
Sale (Purchase) of Intangibles | - | -0.73 | -0.38 | -0.45 | -0.94 |
Investment in Securities | - | 0.65 | 0.4 | 0.42 | 0.16 |
Other Investing Activities | 1.11 | 31.28 | -29.87 | 2.64 | 1.52 |
Investing Cash Flow | -8.76 | 28.05 | -30.96 | 0.93 | -7.8 |
Long-Term Debt Issued | 197 | 189 | 98 | 69.02 | 64.8 |
Long-Term Debt Repaid | -190.35 | -178.58 | -125.11 | -30.81 | -99 |
Net Debt Issued (Repaid) | 6.65 | 10.42 | -27.11 | 38.2 | -34.2 |
Issuance of Common Stock | - | - | - | - | 3.6 |
Common Dividends Paid | - | -5.79 | -6.23 | -5.38 | -5.08 |
Other Financing Activities | -3.9 | -1.55 | -1.45 | - | - |
Financing Cash Flow | 2.75 | 3.07 | -34.79 | 32.82 | -35.68 |
Net Cash Flow | 15.31 | 0.04 | -43.8 | 42.88 | 0.88 |
Free Cash Flow | 11.65 | -34.56 | 19.58 | 7.33 | 35.88 |
Free Cash Flow Growth | - | - | 167.07% | -79.56% | 175.46% |
Free Cash Flow Margin | 1.22% | -4.15% | 2.61% | 1.17% | 6.53% |
Free Cash Flow Per Share | 402.47 | -1193.44 | 676.38 | 253.26 | 1270.88 |
Cash Interest Paid | 0.49 | 1.86 | 1.69 | 0.34 | 0.63 |
Cash Income Tax Paid | 4.81 | 4.88 | 5.88 | 3.98 | 2.75 |
Levered Free Cash Flow | -2.58 | -39.03 | 20.35 | 5.35 | 28.62 |
Unlevered Free Cash Flow | -1.26 | -37.78 | 21.43 | 5.58 | 28.99 |
Change in Working Capital | -3.75 | -55.31 | 0.04 | -9.05 | 27.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.